Recombinant canonical WNT3A induces the expression of TWIST and SNAIL2 and N-cadherin and represses the expression of E-cadherin in HER2 (also known as ERBB2)-expressing breast cancer cells in vitro. Here, WNT3A is linked to breast carcinoma.